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mentation (8-14). Zinc treatment during diarrhoea 
episodes has been shown to decrease duration and 
severity, and to prevent subsequent diarrhoea and 
acute lower respiratory infections over the ensuing 
2-3 months (8,10). Using zinc to treat diarrhoea has 
the potential to avert up to an estimated 400,000 
deaths annually and has been recommended for 
treatment of children with diarrhoea in developing 
countries by UNICEF and WHO (11). Research car-
ried out in Bangladesh, India, and Mali has shown 
that zinc is well-accepted, and most caretakers are 
willing to buy zinc (4,14-17). While zinc has in-
creasingly been used in diarrhoea treatment in 
Asian countries for several years, it has not widely 
been instituted in Africa (14). 
A policy to use zinc to treat children with diarrhoea 
was adopted by the Ministry of Health of Kenya in 
2008. In much of Kenya, healthcare utilization for 
common illnesses is poor. The 2009 Demographic 
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ABSTRACT
Zinc treatment for diarrhoea can shorten the course and prevent future episodes among children world-
wide. However, knowledge and acceptability of zinc among African mothers is unknown. We identified 
children aged 3 to 59 months, who had diarrhoea within the last three months and participated in a 
home-based zinc treatment study in rural Kenya. Caretakers of these children were enrolled in two groups; 
zinc-users and non-users. A structured questionnaire was administered to all caretakers, inquiring about 
knowledge and appropriate use of zinc. Questions on how much the caretakers were willing to pay for 
zinc were asked. Proportions were compared using Mantel-Haenszel test, and medians were compared us-
ing Wilcoxon Rank Sum test. Among 109 enrolled caretakers, 73 (67%) used zinc, and 36 (33%) did not. 
Sixty-four (88%) caretakers in zinc-user group reported satisfaction with zinc treatment. Caretakers in the 
zinc-user group more often correctly identified appropriate zinc treatment (98%-100%) than did those in 
the non-user group (64-72%, p<0.001). Caretakers in the zinc-user group answered more questions about 
zinc correctly or favourably (median 10 of 11) compared to those in the non-user group (median 6.3 of 
11, p<0.001). Caretakers in the zinc-user group were willing to pay more for a course of zinc in the future 
than those in the non-user group (median US$ 0.26, p<0.001). Caretakers of children given zinc recently 
had favourable impressions on the therapy and were willing to pay for it in the future. Active promotion 
of zinc treatment in clinics and communities in Africa could lead to greater knowledge, acceptance, and 
demand for zinc.
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INTRODUCTION
Approximately half of the estimated 7.7 million 
deaths in children aged less than five years in 2010 
occurred in sub-Saharan Africa. About 19% of child-
hood deaths in Africa occur due to diarrhoea (1-3). 
Some of the risk factors of diarrhoeal deaths are in-
gestion of unsafe water, lack of access to proper san-
itation, and deficiency in zinc and vitamin A (2-6). 
Both preventive and therapeutic approaches to di-
arrhoea have the potential to prevent diarrhoea-
related deaths (7). One strategy that has been shown 
to both treat and prevent diarrhoea is zinc supple-
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and Health Survey for Kenya found that only 49% 
of diarrhoeal episodes in Kenyan children resulted 
in a visit to a health facility or care provider (18). As 
such, the majority of diarrhoeal episodes in Kenyan 
children are not treated with zinc. To inform the 
approaches addressing this problem, we carried out 
a cluster-randomized study of the uptake and im-
pact of using zinc to treat diarrhoeal children aged 
less than five years in their homes in rural western 
Kenya. The study was conducted from December 
2007 to April 2009. Within this study population, 
we designed a nested substudy to determine if 
there were any differences between caretakers (usu-
ally mothers) who used zinc for their children’s last 
diarrhoeal episode and those who did not, in terms 
of their acceptance, knowledge, and willingness to 
pay for zinc. Understanding how caretakers accept 
zinc will inform decision-makers in the ministries 
of health in African countries about optimal ways 
to introduce zinc into their healthcare systems.  
MATERIALS AND METHODS
Study setting
Since 2006, International Emerging Infections 
Program of the Centers for Disease Control 
and Prevention (CDC), in collaboration with 
Kenya Medical Research Institute (KEMRI), had a 
population-based infectious disease surveillance 
(PBIDS) in Rarieda division in rural western Ke-
nya (19). The area is one of the poorest in Kenya 
where most people practise subsistence farming 
and where rates of malaria, HIV, and childhood 
infections are high (19,20). PBIDS includes 33 vil-
lages, with an approximate enrolled population 
of 25,000, among whom 3,100 were children aged 
<5 years. The enrolled households were visited ev-
ery two weeks by fieldworkers who inquire about 
key symptoms of major infectious diseases, such 
as diarrhoea, respiratory infections, and malaria. 
All PBIDS participants were entitled to free high-
quality healthcare at a centrally-located mission 
hospital called Lwak Hospital.
Study of zinc treatment at home 
Within 33 villages under the PBIDS area, we un-
dertook a cluster-randomized controlled trial of 
zinc-use in diarrhoea treatment at home for chil-
dren. Villages were stratified by size and randomly 
selected within the strata. All caretakers of children 
from 16 villages received a blister pack of 10 zinc 
tablets and 3 sachets of low-osmolarity ORS every 
2 months at home. Caretakers of children from 17 
villages received only 3 sachets of low-osmolarity 
ORS every 2 months. Caretakers in all villages were 
counselled on the indications and administration 
of zinc and ORS by trained community-based staff 
called ‘village reporters’. Village reporters are often 
traditional birth attendants but are not necessarily 
community health workers. Village reporters un-
derwent a week-long training at the beginning of 
the study on zinc-use and received a two-day re-
fresher training halfway through the study. Care-
takers of children in both the groups were advised 
to take their children to Lwak Hospital when their 
children were ill. At Lwak Hospital, children with 
diarrhoea received zinc if not already taken it at 
home, regardless of whether they were assigned to 
the home zinc treatment group or the non-home 
zinc treatment group. The home zinc treatment 
study began in December 2007 with the last zinc 
distribution in August 2009 at home. At the start of 
the study, zinc had not become available in pub-
lic clinics, although the Ministry of Health had 
decided to adopt zinc for treatment of diarrhoea. 
The general population had little knowledge of or 
experience with zinc. By the end of the study, zinc 
had become available in most clinics under the 
Ministry of Health but not in shops or informal 
pharmacies.
Zinc acceptability study 
This study was carried out between November 
2009 and January 2010 among caregivers of chil-
dren aged 3-59 months enrolled in the main home 
zinc treatment study described above. The caretak-
ers were identified through routine biweekly visits 
for the PBIDS. A list of all children who experienced 
diarrhoea in the last three months was generated 
from PBIDS data. In total, 347 children were cate-
gorized into two groups: those whose last diarrhoe-
al episode was treated with zinc (zinc-users) and 
those whose last episode was not treated with zinc 
(non-users of zinc). To minimize recall bias, we se-
lected 109 caretakers of those children who had the 
most recent diarrhoeal episode. Non-users of zinc 
only referred to diarrhoeal episodes in the past 3 
months, and it is possible that those children were 
treated with zinc for previous diarrhoeal episodes.
Sample-size 
As this was a substudy of the randomized trial, we 
had only a limited budget to interview approxi-
mately 100 caretakers of the study children. We 
determined what difference we could detect, given 
the power of enrolling this number of caretakers. 
We found that we could detect a doubling of the 
willingness to pay from 30% to 60%, assuming 
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a p value of 0.05, power of 80%, and a ratio of 2 
zinc-users for each non-user. We felt that 30% was 
a reasonable assumption for willingness to pay in 
the non-zinc group and also felt that a doubling 
of the willingness to pay constituted a reasonable 
increase that had significant public-health impact. 
We oversampled zinc-users since one of the main 
objectives was to assess the experience of zinc-use 
among caretakers. Since we wanted to know if any 
zinc-use, rather than assignment to the home zinc 
treatment group, influenced willingness to pay, we 
enrolled approximately half of the participants, in 
both zinc-user and non-user groups, from the vil-
lages under home zinc treatment and half from the 
villages under non-home zinc treatment (Table 1). 
The final sample included 73 zinc-users (37 home 
zinc treatment and 36 non-home zinc treatment 
groups) and 36 non-users (18 home zinc treatment 
and 18 non-home zinc treatment groups).  
Data collection
Data were collected using a structured question-
naire. We asked a series of questions about knowl-
edge and acceptability of zinc. Among these, we 
asked 11 Likert-scale questions, including respons-
es ranging from ‘agree’, ‘partially agree’, ‘disagree’ 
to ‘don’t know’. Questions could be framed posi-
tively (e.g. zinc stops diarrhoea quickly or soon) 
or negatively (e.g zinc worsens the severity of diar-
rhoea). Participants were asked to agree or disagree 
with positively- and negatively-framed questions. 
Questions on willingness to pay, treatment, and 
healthcare-seeking for diarrhoea were also asked. 
Interviewers were secondary school graduates who 
underwent a week-long study-specific training on 
questionnaire administration. Interviews were con-
ducted in the local language Dholuo, using agreed 
upon standardized phrasing of questions. Data 
were collected on scannable forms (Teleforms, Car-
diff Inc.). Scanned data were reviewed by specialists 
and corrected where appropriate, or sent back to 
the field team for clarification. 
Statistical analysis
Data were analyzed using SAS (version 9.2, Cary 
NC) and Epi Info (version 2002). Proportions were 
compared using the Mantel-Haenszel  test. During 
analysis of Likert-scale questions about zinc, re-
sponses done correctly or favourably towards zinc 
in terms of acceptability were given a score of 1, 
‘partially agree’ responses were given a score of ½, 
and incorrect responses or ‘don’t know’ were giv-
en a score of 0. Due to non-normal distribution 
of responses, median scores between zinc-users 
and non-users were compared using the Wilcoxon 
Rank Sum test.  
Ethical approval
The protocol was approved by the ethical review 
boards of KEMRI and CDC. Each participant signed 
a written informed consent form.
RESULTS
Of the 3,430 children enrolled in the main home 
zinc treatment study, 347 were reported from PBIDS 
to have had diarrhoea in the last three months, out 
of which we enrolled a sample of 109 (31%) care-
takers of children with the most recent diarrhoeal 
episodes. By design, approximately half (n=55) 







Home zinc treatment group, N (%)               37 (50.7) 18 (50.0) 0.95
Age of children in months (median) 21.6 21.6 0.99
Male children, n (%) 44 (60.3) 19 (52.8) 0.46
Age of mother in years (median) 27.6 27.5 0.37
Mother finished primary school, n (%) 45 (61.6) 23 (65.7*) 0.68
Father has salaried employment, n (%) 7(9.6) 2 (5.6) 0.47
Lowest SES quintile† n (%) 9 (12.3) 4 (11.1) 0.85
2nd-lowest SES quintiles† n (%) 21 (28.7) 5 (13.9) 0.14
*One participant missing mother’s education; †The SES score was derived using multiple component 
analysis (MCA) for all households in the surveillance area. The MCA was generated based on house-
hold characteristics and assets, namely occupation of household head, primary source of drinking-water, 
main source of cooking-fuel, in-house possession (lantern lamp, sofa, radio, bicycle, and TV), and live-
stock ownership (goats, cattle, donkeys, pigs, and sheep)
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were enrolled from the villages that received zinc 
at home and half (n=54) from villages that were 
not provided zinc at home. The median time from 
the most recent diarrhoeal episode to the time of 
enrollment was 63 days for zinc-users and 60 days 
for non-users (p=0.09). Demographic characteris-
tics were similar between zinc-users and non-users 
(Table 1).
Treatment with zinc
Among the 109 enrolled caretakers, 73 reported us-
ing zinc and 36 did not use zinc for their children’s 
most recent diarrhoeal episode. Among the 73 
zinc-users, 18 (25%) received zinc at home, 48 
(66%) obtained zinc at a clinic, 5 (6%) from both 
clinic and at home, and 2 (3%) from other sources 
(e.g. neighbours). Other treatments used for diar-
rhoea were ORS, antibiotics, herbal medicines, and 
intravenous fluids (Table 2). Zinc-users had signifi-
cantly lower use of antibiotics than non-users of 
zinc (20% among zinc-users vs 69% among non-
users of zinc, p<0.001). 
Twenty-one (29%) zinc-users vomited after taking 
the zinc tablet, of whom 17 (81%) vomited only 
after the first dose.
Thirty-six caretakers did not use zinc when their 
children had diarrhoea, reporting the following 
reasons: 16 (44%) did not know where to obtain 
zinc from (5 in home zinc villages and 11 in non-
home zinc villages), 15 (42%) were not prescribed 
zinc from clinic, 4 (11%) were unsure about how 
to administer zinc, and 1 (2.8%) did not know 
about the existence of zinc treatment.
Satisfaction with zinc 
Among the caretakers who gave zinc to their 
children, 50 (69%) reported that they thought 
the zinc tastes better than other medicines, 22 
(30%) felt the taste was similar to other medi-
cines, and one (1.4%) thought the taste was 
worse than other medicines. Sixty-four caretak-
ers (88%) reported being satisfied with the zinc 
treatment.  
Table 2. Care-seeking and treatments administered besides zinc for the most recent episode of diarrhoea, 
Rarieda, Kenya, 2009






ORS 63 (87) 27 (75) 0.09
Antibiotics 15 (20) 25 (69) <0.001
Intravenous fluids 14 (19) 5 (13) 0.49
Prayer 2 (2.8) 3 (8.3) 0.20
Herbal medicine 13 (18) 8 (22) 0.60
Visited clinic 53 (73) 18 (50) 0.02
Among the caretakers of zinc-users, 61 (84%) re-
ported taking the full 10-day course. The most com-
mon reasons for stopping zinc before taking all the 
tablets were that their children were better (n=8) 
or they thought they were supposed to take fewer 
than all 10 tablets (n=4); none indicated that they 
stopped because of unpleasant taste or side-effects. 
Among the zinc-users, 71 (97%) reported to have 
improved appetite after initiating zinc, with most 
(86%) within the first 4 days of treatment. All 73 
(100%) caretakers of zinc-users reported that the di-
arrhoea stopped within 10 days, and 80% reported 
that diarrhoea stopped within the first 4 days of 
starting zinc. Sixty-two caretakers (86%) of zinc-
users reported that they dissolved the zinc tablet 
in breastmilk or water before giving it to the child, 
and 61 (84%) reported that it was not difficult to ad-
minister zinc. The main difficulty reported was that 
the child “did not want to take the zinc tablet”, al-
though the specific reasons why they did not want 
were not further clarified in the questionnaire. 
Knowledge of zinc 
When caretakers of zinc-users were asked for which 
conditions they would recommend zinc for their 
children, all 73 (100%) caretakers of zinc-users 
correctly stated that zinc should be used for wa-
tery diarrhoea compared to 26 (72%) of non-users 
(p<0.001, Table 3).  
Among the caretakers who used zinc, 71 (97%) cor-
rectly reported that zinc should be used for bloody 
or mucousy diarrhoea compared to 23 (64%) of 
the non-users of zinc (p<0.001). The differences be-
tween zinc-users and non-users were found among 
both those in the home zinc and the non-home 
zinc groups (Table 3). There was no difference in 
the percentage of caretakers who said they would 
(inappropriately) use zinc for teething—13 (18%) 
of zinc-users vs 7 (19%) of non-users (p=0.8). Two 
zinc-users would consider use of zinc inappropriate 
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for fever compared to one non-user (p=0.99). No 
caretakers used zinc for cough.  
Acceptability of zinc 
For the 11 Likert-scale questions on acceptability of 
zinc, a score of 11 meant that the caretaker had the 
most favourable impression on zinc, and a score 
of 0 indicated the most unfavourable impression 
(Table 4). Caretakers of zinc-users had a median 
score of 10 while those of non-users had a median 
score of 6.3 (p<0.001). There were no significant 
differences in the scores between caretakers from 
home zinc and non-home zinc villages.  
Willingness to pay
Caretakers of all 73 (100%) zinc-users said they 
would be willing to pay for zinc in the future; the 
median price they would be willing to pay for a 10-
day course of therapy was 20 Kenya Shillings 
(US$ 0.26), ranging from 5 KSh (US$ 0.06) to 200 
KSh (US$ 2.60). Also, all 36 (100%) caretakers of non- 
users of zinc reported a willingness to pay for zinc; 
the median price was 20 Kenya Shillings (US$ 0.26), 
ranging from 10 KSh (US$ 0.13) to 40 KSh (US$ 0.52) 
(Figure). Comparison of the distributions around 
the median amount among groups revealed that 
caretakers of zinc-users were willing to pay more 
(p<0.001); 101 (93%) respondents preferred zinc to 
be available in shops or through community health 
workers rather than only in clinics.
DISCUSSION
Our study demonstrated that caretakers of young 
children with diarrhoea in rural western Kenya, 
who were treated with zinc, had a favourable im-
pression on zinc treatment for diarrhoea. Most were 
‘satisfied’ with the use of zinc in their children and 
found zinc easy to use. This general positive percep-
tion of zinc among mothers and other caregivers 
was similar to what has been observed in Bangla-
desh and Mali (5,6,16,21-23). The most negative 
impression on zinc was that it caused vomiting, 
although this was limited to the first dose in most 
cases—a known adverse event with zinc treatment 
(24) and did not result in stopping the treatment 
course for any patient in our study.    
Knowledge about appropriate zinc-use differed 
significantly between zinc-users and non-users. 
Moreover, zinc-users scored higher than non-users 
on a set of questions that evaluated knowledge and 
acceptability of zinc. In contrast, we saw no dif-
ference in the percentage of zinc-users and non-
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Table 4. Evaluation of acceptability and knowledge of zinc-use to treat diarrhoea among zinc-users and 
non-users by number of questions answered correctly or positively, defined as correctly agree-
ing or disagreeing with the question as phrased, Rarieda, Kenya, 2009








1. Zinc stops diarrhoea quickly or soon 73 (100.0) 16 (44.4) <0.001
2. Zinc worsens the severity of diarrhoea 71 (97.3) 19 (52.8) <0.001
3. Zinc protects the child from getting another 
episode soon
48 (65.8) 11 (30.6) 0.001
4. Zinc is difficult to administer 69 (94.5) 23 (63.9) <0.001
5. Zinc improves the appetite of the child 67 (91.8) 13 (36.1) <0.001
6. Zinc is not good as alternative home remedies 
for diarrhoea
71 (97.3) 26 (72.2) <0.001
7. Zinc is not necessary if diarrhoea is mild 61 (83.6) 14 (38.9) <0.001
8. I would not use new drugs such as zinc if rec-
ommended by my care provider
71 (97.3) 32 (88.9) 0.07
9. Zinc has no side-effect 70 (95.9) 20 (55.6) <0.001
10. Zinc is known and used by mothers in my 
village
58 (79.5) 24 (66.7) 0.15
11. Zinc is highly recommended by healthcare  
  providers
67 (91.8) 26 (72.2) 0.01
Overall score – Median* 10.0  6.3 <0.001
*1 point for correct answer, ½ point for ‘partially agree’ and 0 for incorrect answer or ‘don’t know’
Figure. Cumulative percentage of willingness to pay for zinc treatment among caretakers of children who 
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zinc (e.g. for fever and cough), which was high in 
both the groups. Of note, however, up to 20% of 
caretakers thought that zinc was an appropriate 
treatment for diarrhoea during teething, a notion 
that might derive from the local belief that teeth-
ing children develop diarrhoea, a belief also held in 
rural Mali (4-6).  Importantly, it was rare for parents 
to respond that zinc would be useful to treat fever, 
perhaps allaying fears in this malaria-endemic area 
that parents might delay seeking appropriate treat-
ment for malaria by using zinc instead (4-6). Criti-
cally, zinc-users were less likely to have received 
antimicrobial therapy. Given that the vast majority 
of childhood diarrhoeal episodes within the study 
area were ‘watery diarrhoea’, antimicrobial therapy 
would be unnecessary. Thus, availability of zinc 
therapy may be useful in reducing inappropriate 
use of antimicrobial drugs. Despite this finding, our 
study was not designed to specifically address deci-
sions about antimicrobial-use, and further forma-
tive work is needed to clarify this.
There could be several reasons for the greater level 
of knowledge among caretakers of zinc-users than 
non-users. First, it is possible that those who knew 
more about the benefits and indications for zinc, 
either from education at the home as part of the 
home zinc treatment study or from education at 
the clinic where they were given zinc, were more 
likely to be zinc-users because of that knowledge. 
This is the desired outcome of an educational pro-
gramme. Second, according to the selection crite-
ria, zinc-users used zinc to treat a recent episode 
of diarrhoea. The majority of them obtained zinc 
from the health clinic, and so had recent contact 
with a healthcare worker who likely explained to 
them the indications for zinc-use. If this is the case, 
it suggests that education given in the health fa-
cilities about zinc is retained, perhaps as long as 
60 days after the encounter. Third, the association 
between knowledge and use of zinc might be con-
founded by another variable. While the character-
istics of zinc-users and non-users in terms of mater-
nal age and education, father’s employment, and 
socioeconomic status were similar between the two 
groups, it is possible that there were other differ-
ences between the zinc-users and non-users that we 
could not identify. For example, mothers who are 
more aware of health conditions seek treatment for 
their sick children and also know more about those 
treatments that they seek, such as zinc.  
There was a high level of overall general knowledge 
about zinc-use in this study population in both the 
study areas (including areas where zinc was not 
provided to the caretakers by village reporters). All 
caretakers had a visit from a village reporter every 
two months to deliver ORS and some education on 
diarrhoea. All study participants could obtain zinc 
and information about zinc from Lwak Hospital 
and clinics under the Ministry of Health. Another 
possibility is that knowledge about zinc was preva-
lent in the community through most clinics under 
the Ministry. Therefore, many caretakers might 
have already been exposed to zinc treatment in the 
clinics.  
All participants, both caretakers of zinc-users and 
non-users, said they would be willing to pay for 
zinc. The median amount (approximately US$ 
0.26) they said they would be willing to pay for a 
10-day course of therapy, was comparable to the 
cost of zinc in a community-based zinc introduc-
tion strategy in Mali (US$ 0.19) and in Bangladesh’s 
scale-up campaign (US$ 0.25) (16,22,23). Zinc-
users were willing to pay more than non-users.  
Limitations
Besides possible confounding, our study had sever-
al other potential limitations. First, the study popu-
lation was not representative of the greater popu-
lation, who would not have had the bimonthly 
mini-educational sessions that were given at home 
as part of the randomized controlled trial. Second, 
there might have been selection bias in that care-
takers of children with recent diarrhoeal episodes, 
who were enrolled in this study, might have dif-
fered in their knowledge and attitudes about zinc 
from caretakers of children without recent diar-
rhoeal episodes. Third, we labelled persons as non-
users of zinc if they did not use zinc for their last 
episode, although they might have used it in prior 
episodes. Therefore, caretakers of children in the 
non-user group might have had past experience 
with zinc-use. If this were the case, however, this 
should have biased the findings towards the null 
rather than lead to the differences between groups 
that we found.   
Conclusions
Knowledge and acceptability of zinc was high among 
caretakers who gave their children zinc for a recent 
diarrhoeal episode. Although what caretakers said 
and did might differ, this favourable impression on 
zinc, along with a stated willingness to pay for the 
treatment, suggests that availability of zinc in shops 
or in the community through community health 
workers would likely result in an increase in zinc-use 
for treatment of diarrhoea in rural western Kenya. In 
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this part of Africa, the majority of diarrhoeal episodes 
in children are treated outside the formal healthcare 
system, which is currently the only place to obtain 
zinc from (25). Where healthcare utilization remains 
low, having access to zinc and education about diar-
rhoea management outside the formal health sector 
could increase the use of this important curative and 
preventative treatment.
ACKNOWLEDGEMENTS
This work was supported by funds from Bill & 
Melinda Gates Foundation through a collabora-
tion with icddr,b. We would like to acknowledge 
the Kenya Medical Research Institute for making 
this study possible and permission given by the 
Director to publish this work. We thank the peo-
ple of Rarieda for their support and participation 
in this project. We would like to extend particular 
thanks for contributions to this study by the entire 
field-level data-collectors, supervisors in Rarieda, 
and the Ministry of Health. We also thank Dr. 
Deron Burton for his support and advice.
REFERENCES 
1. Rajaratnam JK, Marcus JR, Flaxman AD, Wang H, 
Levin-Rector A, Dwyer L et al. Neonatal, postneona-
tal, childhood, and under-5 mortality for 187 coun-
tries, 1970–2010: a systematic analysis of progress 
towards Millennium Development Goal 4. Lancet 
2010;375:1988-2008.
2. Black RE, Cousens S, Johnson HL, Lawn JE, Rudan I, 
Bassani  DG et al.; the Child Health Epidemiology Ref-
erence Group of WHO and UNICEF. Global, regional, 
and national causes of child mortality in 2008: a sys-
tematic analysis. Lancet 2010;375:1969-87.
3. Boschi-Pinto C, Velebit L, Shibuya K. Estimating child 
mortality due to diarrhoea in developing countries. 
Bull World Health Organ 2008;86:710-7.
4. Ellis AA, Winch P, Doua Z, Gilroy KE, Swedberg E. 
Home management of childhood diarrhoea in south-
ern Mali—implications for the introduction of zinc 
treatment. Soc Sci Med 2007;64:701-12.
5. Winch PJ, Gilroy KE, Doumbia S, Patterson AE, Daou 
Z, Coulibaly S et al. Prescription and administration 
of a 14-day regimen of zinc treatment for childhood 
diarrhea in Mali. Am J Trop Med Hyg 2006;74:880-3.
6. Gilroy K, Kuszmerski N, Winch P. Lessons learned in 
a pilot introduction of zinc treatment for childhood 
diarrhea in Bougouni, Mali. 2005. (http://www.most-
project.org/ZINC/ZincUpdatesApr05/ZincMaliLes-
sons Learned2005Aprilx.pdf, accessed on 25 August 
2013). 
7. Jones G, Steketee RW, Black RE, Bhutta ZA, Morris SS; 
Bellagio Child Survival Study Group. How many child 
deaths can we prevent this year? Lancet 2003;362:65-71.
8. Bhutta ZA, Bird SM, Black RE, Brown KH, Gardner 
JM, Hidayat A et al.; Zinc Investigators’ Collaborative 
Group. Therapeutic effects of oral zinc in acute and 
persistent diarrhea in children in developing coun-
tries: pooled analysis of randomized controlled trials. 
Am J Clin Nutr 2000;72:1516-22.
9. Baqui AH, Black RE, El Arifeen S, Yunus M, Chakra- 
borty J, Ahmed S et al. Effect of zinc supplementa-
tion started during diarrhea on morbidity and mortal-
ity in Bangladeshi children: community randomised 
trial. BMJ 2002;325:1059-63.
10. Bhutta ZA, Black RE, Brown KH, Gardner JM, Gore 
S, Hidayat A et al.; Zinc Investigators’ Collabora-
tive Group. Prevention of diarrhea and pneumonia 
by zinc supplementation in children in developing 
countries: pooled analysis of randomized controlled 
trials. J Pediatr 1999;135:689-97.
11. United Nations Children’s Fund. WHO/UNICEF 
joint statement: clinical management of acute diar-
rhoea. New York, NY: United Nations Children’s 
Fund, 2004. 7 p.
12. Strand TA, Chandyo RK, Bahl R, Sharma PR, Adhi-
kari RK, Bhandari N et al. Effectiveness and efficacy 
of zinc for the treatment of acute diarrhea in young 
children. Pediatrics 2002;109:898-903.
13. Sazawal S, Black RE, Ramsan M, Chwaya HM, Dutta 
A, Dhingra U et al. Effect of zinc supplementation on 
mortality in children aged 1-48 months: a communi-
ty-based randomised placebo-controlled trial. Lancet 
2007;369:927-34.
14. Fontaine O. Effect of zinc supplementation on clini-
cal course of acute diarrhoea. J Health Popul Nutr 
2001;19:339-46.
15. Larson CP, Saha UR, Nazrul H. Impact monitoring of 
the national scale up of zinc treatment for childhood 
diarrhea in Bangladesh: repeat ecologic survey. PLoS 
Med 2009;6:e1000175.
16. Akhter S, Larson CP. Willingness to pay for zinc treat-
ment of childhood diarrhoea in a rural population of 
Bangladesh. Health Policy Plan 2010;25:230-6.
17. Nasrin D, Larson CP, Sultana S, Khan TU. Accept-
ability of and adherence to dispersible zinc tablet in 
the treatment of acute childhood diarrhoea. J Health 
Popul Nutr 2005;23:215-21.
18. Kenya. Kenya National Bureau of Statistics. Kenya 
demographic and health survey 2008-09. Calverton, 
MD: Kenya National Bureau of Statistics, 2010. 430 
p.
19. Feikin DR, Olack B, Bigogo GM, Audi A, Cosmas L, 
Aura B et al. The burden of common infectious dis-
Otieno GA et al.Zinc to treat childhood diarrhoea in rural Kenya
Volume 31 | Number 3 | September 2013 329
ease syndromes at the clinic and household level 
from population-based surveillance in rural and ur-
ban Kenya. PLoS One 2011;6:e16085.
20. Hamel MJ, Adazu K, Obor D, Sewe M, Vulule J, Wil-
liamson JM et al. A reversal in reductions of child 
mortality in western Kenya, 2003–2009. Am J Trop 
Med Hyg 2011;85:597-605.
21. Bhandari N, Mazumder S, Taneja S, Dube B, Black RE, 
Fontaine O et al. A pilot test of the addition of zinc 
to the current case management package of diarrhea 
in a primary health care setting. J Pediatr Gastroenterol 
Nutr 2005;41:685-7.
22. Larson CP, Roy SK, Khan AI, Rahman AS, Qadri F. 
Zinc treatment to under-five children: applications to 
improve child survival and reduce burden of disease. 
J Health Popul Nutr 2008;26:356-65.
23. Winch PJ, Gilroy KE, Doumbia S, Patterson AE, Daou 
Z, Diawara A et al.; Mali Zinc Pilot Intervention Study 
Group. Operational issues and trends associated with 
the pilot introduction of zinc for childhood diar-
rhoea in Bougouni district, Mali. J Health Popul Nutr 
2008;26:151-62.
24. Larson CP, Hoque AB, Larson CP, Khan AM, Saha 
UR. Initiation of zinc treatment for acute childhood 
diarrhoea and risk for vomiting or regurgitation: a 
randomized, double-blind, placebo-controlled trial. J 
Health Popul Nutr 2005;23:311-9.
25. Bigogo G, Audi A, Aura B, Aol G, Breiman RF, Feikin 
DR. Health-seeking patterns among participants of 
population-based morbidity surveillance in rural 
western Kenya: implications for calculating disease 
rates. Int J Infect Dis 2010;14:e967-73.
